Reproductive disorders in donkeys present a significant challenge to their health and welfare, impacting their roles in agriculture, conservation, and companionship. With the development of large-scale donkey farming in recent years, reproductive disorders have become a limiting factor for the expansion of the donkey population. In general, donkeys suffer from a similar array of diseases like horses, but little is known about the specificities of donkey reproductive disorders. This review synthesizes current knowledge on the pathogenesis, distribution, presentation, diagnosis, treatment, and prognosis of a diverse array of reproductive disorders affecting donkeys. There are similar infectious and non-infectious causes for infertility and pregnancy loss in jennies compared with mares, but a difference in disease susceptibility does exist, which may be attributed to genetic influence, pathogen specificity, the environment, and reproductive management practices. Diagnostic and treatment plans need to be tailored towards the particularities of donkey reproductive disorders to increase donkey populations and to enhance the standard of care for this species. Enhancing reproductive health in donkeys not only ensures their sustainable use but also promotes their welfare and longevity in diverse human–animal interactions.

Equine osteoarthritis (OA) is a major cause of lameness and economic loss in horses. While platelet-rich plasma (PRP) has clinical potential, the biological effects of fresh PRP (F-PRP) and freeze-dried PRP (FD-PRP) remain insufficiently defined. This pilot study compared 25% and 50% F-PRP and FD-PRP in an interleukin-1β-induced equine cartilage-synovium explant co-culture model. PRP treatments reduced inflammatory responses, with significant downregulation of COX-2 and PGE2 expression, and 25% F-PRP showed the most consistent inhibition of nitric oxide production. PRP also significantly reduced glycosaminoglycan release and altered matrix-related gene expression; however, FD-PRP significantly upregulated MMP13, indicating a potential pro-catabolic response. Untargeted LC/MS metabolomics showed that F-PRP and FD-PRP were associated with changes in glucose, purine, amino acid, lipid, and nucleotide metabolism. Growth factor analysis further showed lower PDGF and TGF-β1 concentrations in FD-PRP than in F-PRP. Overall, F-PRP showed more consistent anti-inflammatory and matrix-protective effects, whereas FD-PRP requires further optimization and safety validation before clinical application.

This study characterized the rumen microbiota of Duolang sheep, a Xinjiang local breed, to identify potential probiotics for Hu sheep. 16S rRNA sequencing revealed that Duolang sheep possessed a distinct rumen microbial structure (beta-diversity, p < 0.05), lower diversity (higher Simpson index, p < 0.01), and a higher Firmicutes-to-Bacteroidetes ratio compared to Hu sheep. Subsequently, a Duolang-derived strain, Ligilactobacillus salivarius (L. salivarius) KS1018, was evaluated in a 56-day feeding trial with Hu sheep. Supplementation enhanced systemic immunity (serum IgG and IgM) and antioxidant status (SOD) (p < 0.05). Metabolic profiles were also modified, with serum β-hydroxybutyrate (BHB) level increasing significantly in both medium-dose (p < 0.001) and high-dose (p < 0.05) groups, whereas BUN and lipid markers (TG, CHOL) elevated significantly in the medium-dose (p < 0.05) and high-dose group (p < 0.05), respectively. The strain with medium- and high-dose also reduced fecal crude fat (p < 0.01) and influenced mucosal secretory immunoglobulin A (sIgA) by increasing levels in the duodenum while decreasing them in the rumen (p < 0.05). Ruminal histology was also altered (p < 0.01). Spearman’s correlation analysis showed that Prevotellaceae_UCG-003 was positively correlated with serum BUN (p < 0.001), IgM (p < 0.05), BHB (p < 0.01), and SOD (p < 0.01). Overall, L. salivarius KS1018 improved antioxidant capacity, systemic and mucosal immunity, and ruminal structure in Hu sheep, demonstrating its potential to influence host–microbe interactions in livestock.

Formosan Reeve’s muntjac is a Cervidae species endemic to Southeast China and Taiwan. However, research on different anesthetic protocols, their effects, and their safety in Formosan Reeve’s muntjac is limited. This study evaluated the effects of ketamine-xylazine (KX) and alfaxalone-xylazine (AX) administered via blow darts to nine muntjacs. Induction and recovery times as well as the quality were assessed by a blinded observer. Peripheral oxygen saturation (SpO₂), heart rate, respiratory rate, and rectal temperature were recorded for at least 30 min. Tolazoline (4 mg/kg) was used post-procedure to reverse xylazine’s effects. The mean doses were 4.68 ± 2.18 mg/kg for ketamine and 3.22 ± 1.33 mg/kg for xylazine in the KX group. In the AX group, the mean doses were 4.38 ± 0.31 mg/kg for alfaxalone and 1.19 ± 0.26 mg/kg for xylazine. The median induction times were 339.5 s (range 180.0-375.0) for KX and 125.0 s (range 71.0–334.0) for AX, with both groups scoring 3.0 for induction quality. The recovery times were 507.5 s (range 266.0–1081.0) for KX and 243.0 s (range 92.0–480.0) for AX, with recovery scores of 2.3 and 3.0, respectively, showing no significant difference. Hypoxemia (SpO₂ < 90%) was more severe in the KX group when compared to the AX group (SpO₂ > 92%), and rectal temperatures were higher in the former during the first 15 min. Heart and respiratory rates showed no significant differences between groups. Our findings demonstrate that both anesthetic combinations achieve reliable induction and satisfactory recovery in Formosan Reeve’s muntjac, with the ketamine-xylazine combination causing a more profound hypoxemia post-induction compared to the alfaxalone-xylazine combination.

Rumen-derived probiotics may help regulate fermentation and microbial activity in lambs, but the dose-related effects remain unclear. This study evaluated the effects of rumen-derived Ligilactobacillus salivarius KS1018 on rumen function in Hu lambs using integrated assessments of growth performance, serum hormones, rumen fermentation, rumen microbiota and metabolomics profiling. Thirty-two male Hu lambs were allocated to four groups (n = 8/group): control (C) or KS1018 at 0.5 × 10⁹ (L), 1.0 × 10⁹ (M), or 1.5 × 10⁹ CFU/lamb/day (H) for 56 days. Growth performance, including final BW and ADG, did not differ significantly among groups (p > 0.05). Serum T3 and T4 were significantly higher in M and H than in C (p < 0.01). Group H exhibited significantly lower NH₃-N and higher total VFA concentration of rumen fluid compared with group C (p < 0.05). Significant increases in isobutyric acid concentration were observed in groups M and H (p < 0.05). Genus-level shifts and dose-related metabolite changes were detected; oxidative phosphorylation was enriched in group H and amino acid biosynthesis in group M. Procrustes analysis indicated significant concordance between the rumen microbiome and metabolome datasets (M² = 0.56, p < 0.001). These results indicate that KS1018 supplementation was associated with dose-related changes in rumen fermentation and selected microbiome–metabolome associations in Hu lambs, although the optimal dose requires further validation.